-
Budget Impact Analysis of Inclisiran for the Management of Patients With Atherosclerotic Cardiovascular Disease in India: A Multipayer Analysis
Sep 9, 2025, 16:22 PM -
Defining Patient-Centered Outcomes in CAR-T-cell Therapy: Is There a Need for a Patient-Informed CAR-T PROM?
Sep 9, 2025, 16:22 PM -
Generating Data for Diversity Planning in Breast Cancer: A Multi-Database Validation Study Using US Claims and HER, Population Census, and Cancer Registry Data in the United States
Sep 9, 2025, 16:22 PM -
Analysis of the Impact of the TelE-Medicine Program for Medically Underserved Area on Hospitalization Rates Among Diabetic Patients in Medically Underserved Areas
Sep 9, 2025, 16:22 PM -
Advancing Patient-Centered Value Assessment in Inherited Retinal Diseases: Leveraging EQ-5D-5L Vision Bolt-ons to Support IRD-Specific PROMs
Sep 9, 2025, 16:22 PM -
Pulmonary Nodule (PN)-Related and Lung Cancer-Related Workup Costs Within the Two-Year Period After Diagnosis of a PN in the United States
Sep 9, 2025, 16:22 PM -
Innovation on Hold: A 2020-2025 Analysis of the Conditional Drug Reimbursement Framework
Sep 9, 2025, 16:22 PM -
Feasibility Evaluation of Claims Database: Best Practices and Case Study for a Comparative Analysis of Robotic-Assisted Colorectal Surgery in Germany
Sep 9, 2025, 16:22 PM -
Real-World Treatment Patterns and Outcomes in First-Line Small-Cell Lung Cancer (SCLC) in France
Sep 9, 2025, 16:22 PM -
A Cost-Effectiveness Analysis of Ustekinumab Against Vedolizumab Among Inflammatory Bowel Disease Patients With Extra-intestinal Manifestations in Egypt
Sep 9, 2025, 16:22 PM -
Predictors of Effectiveness of Biologic and Targeted Synthetic Disease Modifying Antirheumatic Drugs in the Treatment of Rheumatoid Arthritis
Sep 9, 2025, 16:22 PM -
Assessing the Economic Impact of Biosimilars in Europe: A Cost Analysis of Infliximab, Trastuzumab, and Rituximab
Sep 9, 2025, 16:22 PM -
Linking Data to Care: Mining the Pathways of Oncology
Sep 9, 2025, 16:22 PM -
Evaluating GenAI vs. Human Screenshot Review Outputs in eCOA Localization: Does AI Hold the Key to Improved Feedback?
Sep 9, 2025, 16:22 PM -
Analysis of the Breast Cancer Diagnosis Program: A Window of Opportunity
Sep 9, 2025, 16:22 PM -
The Health Impact of Pembrolizumab for the First-Line Treatment for Metastatic Non-Small Cell Lung Cancer (mNSCLC) That Expresses High Levels of PD-L1 in Türkiye
Sep 9, 2025, 16:22 PM -
Establishing Robust and Adaptive Willingness-to-Pay Thresholds for Taiwan's National Health Insurance: A Case Study of Non-Small Cell Lung Cancer
Sep 9, 2025, 16:22 PM -
Artificial Intelligence-Powered Literature Reviews (AILRs): Streamlining Joint Clinical Assessment (JCA) Dossier Preparation for the Next Generation of Pharmaceutical Submissions
Sep 9, 2025, 16:22 PM -
Perceived Impact and Actionability of Barriers to Drug Repurposing: Insights From a Multistakeholder Policy Survey
Sep 9, 2025, 16:22 PM -
Modeling What Matters: The Real-World Burden of Pregnancy-Related Complications in cTTP
Sep 9, 2025, 16:22 PM
